Neuca SA
WSE:NEU
Intrinsic Value
NEUCA SA engages in the wholesale of pharmaceutical products. [ Read More ]
The intrinsic value of one NEU stock under the Base Case scenario is 1 503.98 PLN. Compared to the current market price of 945 PLN, Neuca SA is Undervalued by 37%.
Valuation Backtest
Neuca SA
Run backtest to discover the historical profit from buying and selling NEU stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Neuca SA
Current Assets | 3.3B |
Cash & Short-Term Investments | 119.5m |
Receivables | 1.7B |
Other Current Assets | 1.5B |
Non-Current Assets | 1.9B |
Long-Term Investments | 84.8m |
PP&E | 658.7m |
Intangibles | 1.1B |
Other Non-Current Assets | 17.4m |
Current Liabilities | 3.8B |
Accounts Payable | 3.3B |
Accrued Liabilities | 13.1m |
Short-Term Debt | 159.8m |
Other Current Liabilities | 334.2m |
Non-Current Liabilities | 418.9m |
Long-Term Debt | 151m |
Other Non-Current Liabilities | 268m |
Earnings Waterfall
Neuca SA
Revenue
|
11.8B
PLN
|
Cost of Revenue
|
-10.5B
PLN
|
Gross Profit
|
1.3B
PLN
|
Operating Expenses
|
-1B
PLN
|
Operating Income
|
265.8m
PLN
|
Other Expenses
|
-119.5m
PLN
|
Net Income
|
146.3m
PLN
|
Free Cash Flow Analysis
Neuca SA
NEU Profitability Score
Profitability Due Diligence
Neuca SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Neuca SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
NEU Solvency Score
Solvency Due Diligence
Neuca SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Neuca SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NEU Price Targets Summary
Neuca SA
According to Wall Street analysts, the average 1-year price target for NEU is 919.28 PLN with a low forecast of 757.5 PLN and a high forecast of 1 119.3 PLN.
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
Contact
IPO
Employees
Officers
The intrinsic value of one NEU stock under the Base Case scenario is 1 503.98 PLN.
Compared to the current market price of 945 PLN, Neuca SA is Undervalued by 37%.